Effect of dulaglutide 3.0 and 4.5 mg on weight in patients with type 2 diabetes: Exploratory analyses of AWARD‐11

AIM: To evaluate the impact of dulaglutide 3.0 and 4.5 mg versus 1.5 mg on body weight in patients with type 2 diabetes (T2D) based on exploratory analyses of the AWARD‐11 trial. MATERIALS AND METHODS: Patients were randomized to once‐weekly dulaglutide 1.5 (n = 612), 3.0 (n = 616) or 4.5 mg (n = 61...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonora, Enzo, Frias, Juan P., Tinahones, Francisco J., Van, Joanna, Malik, Raleigh E., Yu, Zhuoxin, Mody, Reema, Bethel, Angelyn, Kwan, Anita Y. M., Cox, David A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518850/
https://www.ncbi.nlm.nih.gov/pubmed/34189841
http://dx.doi.org/10.1111/dom.14465

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8518850/
https://www.ncbi.nlm.nih.gov/pubmed/34189841
http://dx.doi.org/10.1111/dom.14465

Ejemplares similares